25.13
前日終値:
$24.55
開ける:
$25
24時間の取引高:
297.61K
Relative Volume:
0.92
時価総額:
$1.73B
収益:
$751.00K
当期純損益:
$-74.57M
株価収益率:
-22.78
EPS:
-1.1031
ネットキャッシュフロー:
$-54.46M
1週間 パフォーマンス:
+31.97%
1か月 パフォーマンス:
+7.61%
6か月 パフォーマンス:
+85.42%
1年 パフォーマンス:
+46.48%
Pulse Biosciences Inc Stock (PLSE) Company Profile
Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences Inc
|
25.00 | 1.70B | 751.00K | -74.57M | -54.46M | -1.1031 |
|
ISRG
Intuitive Surgical Inc
|
437.90 | 149.15B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
142.64 | 39.53B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
65.57 | 31.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
35.53 | 30.60B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
204.73 | 29.28B | 5.54B | 1.52B | 1.74B | 10.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | 開始されました | Mizuho | Outperform |
| 2025-07-07 | 開始されました | Oppenheimer | Outperform |
| 2021-07-27 | 開始されました | Stephens | Overweight |
| 2021-03-11 | 開始されました | Maxim Group | Buy |
| 2021-01-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-12 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Pulse Biosciences Inc (PLSE) 最新ニュース
PLSE accelerates cardiac catheter program after breakthrough AFib data - MSN
Pulse Biosciences CEO Buys 15,000 Shares: SEC Filing Details | May 2026News and Statistics - IndexBox
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. - Yahoo Finance
(SEC Amendment) Pulse Biosciences(PLSE.US) 10% Shareholder Buys US$13 Million in Common Stock - Moomoo
Pulse Biosciences director Robert W. Duggan acquires $13m in stock - Investing.com India
Director Robert Duggan buys 660K Pulse Biosciences (PLSE) shares - Stock Titan
Pulse Bio rises after over $13M insider buying - MSN
Pulse Biosciences stock hits 52-week high at 26.33 USD By Investing.com - Investing.com Nigeria
Pulse Biosciences, Inc. Q1 2026 Financial Report – Revenue, Losses, and Key Corporate Updates - Minichart
Pulse Biosciences Announces Clinical Data From nPulse Vybrance System Study - Medical Product Outsourcing
Pulse Biosciences stock hits 52-week high at 26.33 USD - Investing.com India
Pulse Biosciences stock (US73242P1030): Q1 2026 net loss widens to $18.6M on early commercialization - AD HOC NEWS
PULSE BIOSCIENCES, INC. 1Q 2026: Revenue $401K, EPS ($0.27) — 10-Q Summary - TradingView
Pulse Biosciences Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Pulse Biosciences (NASDAQ: PLSE) Q1 2026 results, cash burn and AF strategy - Stock Titan
Pulse Biosciences, Inc. (PLSE) Presents at Bank of America Global Healthcare Conference 2026Slideshow - Seeking Alpha
[SCHEDULE 13D/A] PULSE BIOSCIENCES, INC. Amended Major Shareholder Report - Stock Titan
Pulse Biosciences Insider Bought Shares Worth $12,999,988, According to a Recent SEC Filing - Moomoo
Pulse Biosciences stock jumps after insiders buy $13.3M in shares - Investing.com Canada
Pulse Biosciences (PLSE) Co-Chairmen Invest $13.3M in Company St - GuruFocus
Pulse Biosciences (PLSE) Stock Soars After Insider Buying - GuruFocus
Pulse Biosciences (PLSE) Stock Surges 17% on Major $13M Insider Purchase - MEXC
Pulse Biosciences stock (US73242P1030): CEO buys $295K in shares - AD HOC NEWS
Pulse Biosciences (PLSE) Stock Jumps 17% After $13M Insider Buy - MEXC Exchange
Pulse Biosciences stock jumps after insiders buy $13.3M in shares By Investing.com - Investing.com South Africa
Pulse Bio rises after over $13M insider buying (PLSE:NASDAQ) - Seeking Alpha
Pulse Biosciences insiders buy $13.3 million in stock By Investing.com - Investing.com South Africa
Pulse Biosciences insiders buy $13.3 million in stock - Investing.com
ATM equity purchases by Pulse Biosciences' co-chairmen total approximately $13.3 million - marketscreener.com
ATM Equity Purchases By Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million - TradingView
$13.3M insider stock buy: Pulse Biosciences chiefs add 675K shares - Stock Titan
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million - marketscreener.com
Pulse Biosciences Insider Bought Shares Worth $295,350, According to a Recent SEC Filing - Moomoo
ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million - 富途牛牛
Insider Buying: Paul Laviolette Acquires 15,000 Shares of Pulse Biosciences Inc (PLSE) - GuruFocus
Pulse Biosciences CEO Paul LaViolette acquires $295,350 in shares - Investing.com India
Pulse Biosciences CEO Paul LaViolette acquires $295,350 in shares By Investing.com - Investing.com Nigeria
Pulse Biosciences (NASDAQ: PLSE) CEO adds 15,000 shares in open-market buy - Stock Titan
Pulse Biosciences Inc (PLSE) 財務データ
収益
当期純利益
現金流量
EPS
Pulse Biosciences Inc (PLSE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
May 11 '26 |
Buy |
19.69 |
660,233 |
12,999,988 |
48,211,433 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Option Exercise |
1.53 |
5,000 |
7,650 |
48,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Sale |
23.64 |
5,000 |
118,200 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 12 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 13 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 17 '26 |
Option Exercise |
1.53 |
20,000 |
30,600 |
63,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 17 '26 |
Sale |
23.63 |
20,000 |
472,600 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 13 '26 |
Sale |
23.53 |
20,000 |
470,600 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 12 '26 |
Sale |
23.37 |
20,000 |
467,400 |
43,298 |
大文字化:
|
ボリューム (24 時間):